NewsfeedFollowed Companies

Recipharm's Competitors, Revenue, Number of Employees, Funding and Acquisitions

Recipharm is a contract development and manufacturing organization specializing in pharmaceutical products.

Recipharm's h... Read more

Annual Revenue

Employees

Thomas Eldered's photo - President & CEO of Recipharm

President & CEO

Thomas Eldered

CEO Approval Rating

84/100

OVERVIEW

Founded:

1995

Headquarters:

StockholmStockholms län

Status:

PublicIndependent Company of OtherRECI-B

Industry Sector:

- -

SIC Code:

8000NAICS listing »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Aesica a competitor of Recipharm?

I don't know

Trending News for Recipharm and Recipharm's Competitors

January 17, 2020

Contract Pharma

Catalent Strengthens Biologics Business

Makes key senior appointments.... See more »

January 15, 2020

FinanzNachrichten

Cardiol Therapeutics' Exclusive Manufacturing Partner Receives Three-Year Renewal and Amendment of its Cannabis Act License from Health Canada

Oakville, Ontario--(Newsfile Corp. - January 15, 2020) - Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX... See more »

January 17, 2020

Contract Pharma

BridgeBio Pharma, Catalent Enter Gene Therapy Alliance

Deal is designed to accelerate BridgeBio's gene therapy programs; dedicated suite will support clinic... See more »

Competitive Analysis

TOP COMPETITORS OR ALTERNATIVES

DPT Laboratories is one of Recipharm's top competitors. DPT Laboratories was founded in 1938 in San Antonio, Texas. DPT Laboratories operates in the Pharmaceuticals industry. DPT Laboratories generates $423.6M less revenue than Recipharm.

WellSpring is a top competitor of Recipharm. WellSpring was founded in 2001, and is headquartered in Oakville, Ontario. WellSpring is in the Pharmaceuticals industry. WellSpring generates $613.6M less revenue vs. Recipharm.

PharmaTech is seen as one of Recipharm's top competitors. PharmaTech is headquartered in Davie, Florida, and was founded in 2009. PharmaTech is in the Pharmaceuticals field. PharmaTech generates 4.47% the revenue of Recipharm.

RANK

COMPANY

LEADERSHIP

CEO SCORE

EMPLOYEES

TOTAL FUNDING

REVENUE

Thomas Eldered

President & CEO

- -
4,572
$32M
$648.8M
1

CEO

- -
1,100
- -
$225.2M
2

CEO

- -
120
- -
$35.2M
3

Thurman Michel

President & CEO

82/100
66
- -
$29M
4

Mohammad Naraghi

CEO

70/100
- -
5

Manja Boerman

Managing Director

70/100
1,300
- -
$25M
6

CEO

- -
9,100
$625M
$1.9B
7

Eric Dann

Founder & CEO

90/100
356
- -
$100M
8

John Chiminski

Chairman & CEO

71/100
10,700
$1.5B
$2.6B
9

Salim Haffar

CEO

77/100
2,800
- -
$450M
10

Michael Quirmbach

President & CEO

83/100
1,375
- -
$355.7M
The top 10 competitors in Recipharm's competitive set are DPT Laboratories, WellSpring, PharmaTech, Aenova Holding, Aesica, Patheon, Formulated Solutions, Catalent, PCI and CordenPharma. Together they have raised over 2.1B between their estimated 28.5K employees. Recipharm has 4,572 employees and is ranked 3rd among it's top 10 competitors. The top 10 competitors average 3,148.

Quarterly and Annual Revenue

Coming soon for Recipharm!

Annual Revenue

$648.8M

Recipharm's revenue is the ranked 3rd among it's top 10 competitors. The top 10 competitors average 643.3M.

Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Consort Medical Plc

Nov 2019

Source »
$649M
Consort Medical is a contract developer and manufacturer of drug delivery devices that include nasal inhalers and pharmaceutical compounds.
Mitim S.r.l.

Feb 2016

Source »
$75.5M
Mitim develops and manufactures beta lactams in dry sterile powder for injectable solutions, tablets and oral suspensions.

-

-

Dec 2015

Source »
$19.5M
-
Nitin Lifesciences India

Oct 2015

Source »
$103.5M
Nitin Lifesciences is engaged in contract manufacturing of liquid ampoules, liquid vials, sterile dry powder, multidose eye and ear drops.
Ontarget Chemistry Ab

Jun 2015

Source »
$1.8M
OnTarget Chemistry is a chemistry contract research organization that offers quality synthetic and analytical chemistry services.

These are all the companies that Recipharm has acquired. Recipharm has acquired 6 companies and its latest acquisition was Consort Medical Plc in Nov 2019. Consort Medical is a contract developer and manufacturer of drug delivery devices that include nasal inhalers and pharmaceutical compounds.

Recipharm Funding History

Since Recipharm was founded in 1995, it has participated in 1 round of funding. In total Recipharm has raised $32.0M. Recipharm's funding round was on Jan 2016 for a total of $32.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
Jan 2016
$32M
-

Total Funding: $32M

Since Recipharm was founded in 1995, it has participated in 1 round of funding. In total Recipharm has raised $32.0M. Recipharm's funding round was on Jan 2016 for a total of $32.0M

Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

LIDDS engages in researching and developing medicines and drugs for the treatment of prostate cancer.
$500K
Dec 16, 2015
Unattributed
-
Pharmanest is developing pain relief formulations based on well-known active substances. 
$3.3M
Jul 08, 2015
Equity
-
Synthonics is a pharmaceutical firm focused on novel drug discovery and development. 
-
Apr 13, 2015
Equity
-

These are all the companies that Recipharm has invested in. Recipharm has invested 6 companies and its latest investment was Consort Medical Plc in Nov 2019. Consort Medical is a contract developer and manufacturer of drug delivery devices that include nasal inhalers and pharmaceutical compounds.

Recipharm News

December 17, 2019Manufacturing Chemist

Swedish biotech chooses Recipharm for sepsis drug manufacturing

Recipharm has signed a deal with Aptahem to develop an injectable formulation for an upcoming Phase 1... See more »
December 9, 2019Contract Pharma

Recipharm Invests in Inhalation Development Services

Installs SprayVIEW system to support inhalation and nasal product development at RTP, NC facility... See more »
December 6, 2019MarketScreener

Publication of Offer Document

(marketscreener.com) NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR F... See more »
December 6, 2019Cision

Recipharm publishes Offer Document regarding offer to acquire Consort Medical

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION W... See more »
December 5, 2019Manufacturing Chemist

Recipharm begins production of soon-to-be-launched Talicia

The Swedish CDMO has started commercial-scale manufacturing of RedHill's drug following US FDA approv... See more »
December 4, 2019Contract Pharma

Recipharm, RedHill Biopharma Ink Commercial Mfg. Pact

CDMO offers commercial manufacturing to support Talicia Q1/2020 launch following FDA approval.... See more »
November 26, 2019FE Investegate

Update on Recipharm rights issue participation

7:00 AM: (0QSD) Update on Recipharm rights issue participation... See more »

Recipharm Press Releases

May 24, 2016GlobalNewswire

Listing of subscription rights and paid subscription shares in Recipharm AB (publ) (73/16)

See more »
May 19, 2016GlobalNewswire

Recipharm publishes prospectus

See more »
May 8, 2016Scoopasia

Comparative Analysis, Shares and Latest Updates Report, 2015-2020

See more »
April 16, 2016GlobalNewswire

Notice to attend the Extra Ordinary General Meeting of Recipharm AB (publ)

See more »
April 16, 2016GlobalNewswire

Recipharm creates a global CDMO leader through SEK 1.7 billion strategic acquisitions in the US, Sweden and India

See more »
March 4, 2016M2 PressWIRE

Recipharm reports on nomination committee proposals for board of directors before Annual General Meeting 2016

See more »
January 28, 2016AB Newswire

Key Major Players are Recipharm, Catalent Pharma Solutions Inc. & Aurobindo Pharma Limited

See more »

Headquarters

Box 603

Stockholm, Stockholms länSE-101 32

46-8-602-5200

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Recipharm is a contract development and manufacturing organization specializing in pharmaceutical products. Recipharm was founded in 1995. Recipharm's headquarters is located in Stockholm, Stockholms län, SE SE-101 32. It has raised 32.0M in 1 round. ...

CEO

Recipharm's President & CEO, Thomas Eldered, currently has an approval rating of 84%. Recipharm's primary competitors are DPT Laboratories, WellSpring & PharmaTech.

Website

recipharm.com

Frequently Asked Questions about Recipharm

  1. When was Recipharm founded?

    Recipharm was founded in 1995

  2. Who is Recipharm's CEO?

    Recipharm's CEO is Thomas Eldered

  3. How much revenue does Recipharm generate?

    Recipharm generates $648.8M in revenue

  4. How much funding does Recipharm have?

    Recipharm has historically raised $32M in funding

  1. Where is Recipharm's headquarters?

    Recipharm's headquarters is in Stockholm Stockholms län, SE

  2. How many employees does Recipharm have?

    Recipharm has 4,572 employees

  3. Who are Recipharm's competitors?

    Recipharm's top competitors are DPT Laboratories, WellSpring, PharmaTech

  4. Who has Recipharm invested in?

    Recipharm's has invested in companies such as Liddspharma, Pharmanest, Synthonics
Stay up-to-date with the latest news on Recipharm